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Abstract. Gene cloning and sequencing of the HLA-B 
locus split antigens B38 (B16.1) and B39 (B16.2) allowed 
localization of their subtypic as well as their public 
specificities HLA-Bw4 or -Bw6 to the c~-helical region of 
the c~ 1 domain flanked by the amino acid positions 74-83. 
Comparison of their amino acid sequences with those of 
other HLA-B-locus alleles established HLA-Bw6 to be 
distinguished by Ser at residue 77 and Asn at residue 80. 
In contrast, HLA-Bw4 is characterized by at least seven 
different patterns of amino acid exchanges at positions 77 
and 80-83. Reactivity patterns of Bw4- or Bw6-specific 
monoclonal antibodies reveal two alloantigenic epitopes 
contributing to the HLA-Bw4 or -Bw6 specificity residing 
next to the region of highest diversity of the cr domain. 
Introduction 
HLA class I antigens are polymorphic membrane 
glycoproteins with ubiquitous distribution on almost all 
nucleated cells. They bind peptides of processed antigens 
and present them to cytotoxic T lymphocytes (CTL; Ger- 
main 1986, Chen and Parham 1989). Initially, class I an- 
tigens controlled by the HLA-A, B, C loci were differen- 
tiated by the reactivity patterns mainly of pregnancy 
alloantisera with individual cells. Development and use 
of specific monoclonal antibodies, as well as T-cell 
responses and biochemical analyses, revealed extensive 
structural heterogeneity of these molecules. HLA-A, B, C 
antigens were thus shown to express avariety of different 
antigenic determinants. Like the antigens of the H-2 
system in the mouse (summarized in Klein 1986), some 
of the HLA antigens are unique and define particular HLA 
alleles as so-called private specificities, whereas others 
are termed supertypic or public specificities because they 
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are shared by several allelic products of a single locus or 
even by molecules encoded by different HLA loci. The 
earliest known supertypic HLA determinants were the 
HLA-Bw4 and -Bw6 specificities (van Rood 1962). Either 
of them is expressed together with a particular private 
specificity on a given HLA-B molecule (Ayres and 
Cresswell 1976). While the HLA-Bw4 determinant is
found in addition on the HLA-A-locus antigens A24, A23, 
and A32 (Kostyu et al. 1980), the HLA-Bw6 public 
specificity is also present on the product of the HLA- 
C-locus allele Cw3 (Layet et al. 1985). Molecular variants 
of the Bw4 specificity have been reported based on the 
serological reactivity patterns of different Bw4-specific 
monoclonal antibodies (Miiller et al. 1985a, Miiller et al. 
1982). Recent cloning and sequencing of a number of dif- 
ferent HLA alleles (Parham et al. 1988), as well as deter- 
mination of the X-ray crystallographic structure of the 
HLA-A2 antigen (Bjorkman et al. 1987), has facilitated 
localization of various alloantigenic epitopes detected by 
monoclonal antibodies or recognized by CTL. Com- 
parison of the primary structure of HLA-B and -A 
molecules (Wan et al. 1986), as well as exon shuffling 
experiments with HLA-B 7 and -B2 7 genes (Toubert et al. 
1988), recently suggested that the Bw4 and Bw6 
specificities map to the first external domain, in particular 
to the amino acid residues 79-83. To characterize further 
genetic and structural heterogeneity of Bw4 and Bw6, we 
have exploited their association with the HLA-B antigens 
B38 and B39 which as subtypes of the HLA-B16 antigen 
are highly cross-reactive, but differ in the expression of 
these supertypic specificities. 
Materials and methods 
Cells. Peripheral b ood leucocytes (PBL) were obtained from healthy 
donors after Ficoll hypaque density gradient centrifugation. HLA 
serotyping was performed byroutine cytotoxicity assays using local stan- 
dardized antisera, s well as antibodies of the Tenth International 
Histocompatibility Workshop. PBL of donor S with the HLA phenotype 
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A2, A33, B44, B39, Cw5, Bw4, Bw6 and of donor Z with the HLA 
phenotype A26, Bw64, B38, Cw8, Bw4, Bw6 were selected for cloning 
of the B38 and B39 genes. All Epstein-Barr virus transformed B-cell 
lines were obtained from the Tenth International Histocompatibility 
Workshop cell-line panel with well-characterized HLA phenotype and 
genotype, and grown in RPMI 1640 medium supplemented with 10% 
fetal calf serum (FCS). L(tk ) ceils, kindly provided by W. Summer 
(Yale University, New Haven, Connecticut), were maintained in 
Dulbecco's modified Eagle's medium (DMEM, Boehringer Mannheim, 
Mannheim, FRG) supplemented with 10% FCS. 
Monoclonal ntibodies. The monoclonal ntibodies (mAbs) W6/32.HL 
(anti-HLA-ABCE heavy chain) and its inactive variant W6/32.HK were 
obtained from A. Ziegler (Institute of Immunology, Marburg, FRG; 
Barnstable et al. 1978). The antibody 4E (Yang et al. 1984) was kindly 
provided by S. Y. Yang (Sloan Kettering Institute, New York, USA). 
The Bw4-specific antibodies T13109 (Miiller et al. 1985a) and T1148 
(Miiller et al. 1982) as well as the A2- and A28-specific mAb TI3101 
(MOiler et al. 1983) from our laboratory have been described previously. 
The 2BC4 (Kandzia et al. 1981) and the SFR8-B6 antibodies (Radka 
et al. 1982) directed against HLA-Bw6 were generous gifts of E. 
Westphal (Institut for Hygiene, Kiel, FRG) and S. Radka (Duke Univer- 
sity, Durham, USA), respectively. Further BW4- or BW6-specific 
monoclonal reagents, as well as A2- or A26-specific mAbs, were ob- 
tained during the Tenth International Histocompatibility Workshop. 
Probes. HLA-B genes were isolated by using HLA-A and -B locus- 
specific probes derived from the HLA-B7 cDNA and the HLA-A2 gene 
as described by Koller and co-workers (Koller et al. 1984). The HLA- 
B27 (Weiss et al. 1985) and -B51 genes (Pohla et al. 1989) have been 
described previously. The HLA-Cw3 gene (Sodoyer et al. 1984) was 
a gift ofB. R. Jordan (CNRS, Marseille, France). The HLA-A2 and -B7 
genes (Barbosa et al. 1982), as well as the HLA-B7 cDNA probe (Sood 
et al. 1981), were kindly provided by S. Weissman (Yale University, 
New Haven, Connecticut). 
DNA analysis. DNA extraction, restriction endonuclease mapping, and 
Southern blot hybridizations using specific 32p multiprimed labeled 
probes under highly stringent conditions were carried out according to 
the procedures described earlier (Williams et al. 1987, Feinberg and 
Vogelstein 1983). 
Isolation ofgenomic clones. Genomic DNA extracted from lymphocytes 
of donor S and Z was completely digested with Eco RI and electropho- 
resed on a preparative 0.7 % agarose gel. DNA fragments (6 kbp long) 
eluted from the gels were cloned in the Eco RI site of lambda gtl 1 (Pro- 
mega, Madison, Wisconsin) as described previously (Williams et al. 
1987). The two independent partial genomic libraries were screened by 
hybridization with HLA-B7 cDNA and HLA-A or -B locus-specific pro- 
bes under highly stringent conditions. Positive clones hybridizing with 
HLA-B7 cDNA and the HLA-B locus-specific probe were plaque 
purified. 
Tran~fection f cloned genes. Cloned HLA genes were cotransfected with 
the thymidine kinase gene into mouse L(tk-) ceils by the calcium 
phosphate precipitation method as described earlier (Wigler et al. 1979). 
As controls, L(tk-) cells were transfected with the thymidine kinase 
gene only. After selection in HAT medium (DMEM supplemented with 
15 Ixg/ml hypoxanthine, 1 I.tg/ml aminopterin, and 5 Ixg/ml thymidine), 
colonies were picked and grown in mass culture. 
lmmunofluorescence analysis. Indirect immunofluorescence labeling of 
PBL and transfectants was performed with the use of poly- and 
monomorphic monoclonal HLA-specific antibodies and evaluated on 
fluorescence-activated c llsorter (FACS) IV as previously described 
(MOiler et al. 1985b). 
Radioimmunoassay. Surface HLA expression of transfectants was 
analyzed by a quantitative radioimmunoassay using the monomorphic 
monoclonal antibodies W6/32.HL and 4E, as well as the polymorphic 
monoclonal antibodies TIJ109 and 2BC4 as reported earlier (Schmidt 
et al. 1987). 
Isoelectricfocusing (IEF) analysis. Isoelectric focusing was carried out 
on HLA class I products immunoprecipitated with the monoclonal an- 
tibodies W6/32.HL or 4E from 35S-labeled transfectants and PBL of 
donor S and Z according to the procedure described previously (Yang 
et al. 1984, Yang 1989). PBL were stimulated with phytohemagglutinin 
overnight, ransfectants with mouse interferon for 24 h before labeling. 
DNA sequencing. After restriction endonuclease mapping of recombi- 
nant clones, subcloning of appropriate fragments up to about 500 bp 
was performed into pUC13. Supercoil DNA sequencing according to 
Chen and Seeburg (1985) was carried out by the dideoxy chain termina- 
tion method (Sanger et al. 1977) using Sequenase VM (United States 
Biogenical Corporation, Fa. Renner, Dannstatt, FRG) or Taq 
polymerase (Stratagene, Heidelberg, FRG). 
Results 
Cloning of HLA-B38 and -B39 genes. HLA-B38(Bw4) and 
HLA-Bw39(Bw6) genes were obtained from partial 
genomic l ibraries of  two German Caucasian individuals 
who were serologically typed heterozygous for the super- 
typic determinants Bw4/Bw6. IEF  analysis of  im- 
munoprecipitated HLA class I antigens and comparison 
with previously established band patterns of  HLA-A ,  -B, 
-C allelic products (Yang 1989) revealed that donor S 
expressed the HLA-B-locus subtypes Bw44.2(Bw4) 
B39(B16.2; Bw6), whereas donor Z ' s  genotype was 
Bw64(Bw6), B38(B16.1; Bw4; data not shown). On the 
basis of  Southern blot hybridization of  Eco RI-digested 
genomic DNA with the HLA-B locus-specif ic probe, it ap- 
peared that HLA-B genes were included in 6-kb fragments 
of  both donors exclusively. F rom each of  the two partial 
genomic libraries established from these fragments, four 
recombinant lgt l  1 clones which strongly hybridized with 
the HLA-B locus-specif ic probe were selected for transfec- 
tion of  L(tk-) cells. The transfected cells were shown in 
radioactive binding assays with poly- and monomorphic  
monoclonal  antibodies to express Bw4- or Bw6-posit ive 
HLA-B  products (Table 1). No reactivity was seen with 
the monoclonal  antibodies TIS101 [anti-A2, A28; (Mtiller 
et al. 1983)] or Tenth International Histocompatibi l i ty 
workshop 2066 and 2067 mAbs specific for A2 or A26, 
ruling out the possibil ity that these clones encoded A2 or 
A26 of donor 's  S or Z lymphocytes (data not shown). The 
identity of  the HLA-B38 and -B39, as well  as of  the HLA- 
Bw64 genes, was further established by IEF  analysis of  
the expressed, immunoprecipitated HLA class I molecules 
from the transfectants in comparison with the respective 
products from the donor 's  lymphocyts (data not shown). 
Weak binding o f  4E and W6/32 .HL ,  but not of  T(2109 
or 2BC4, on L(tk--) ceils transfected with clone S l . l . a  
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Table 1. Identification of the cloned genes after expression in mouse L cells by an indirect radioactive binding assay with the mAb W6/32.HL 
(common HLA-ABCE), 4E (HLA-B and C), 2BC4 (HLA-Bw6), TiJ109 (HLA-Bw4). 
Transfected Donor mAb Reactivity on transfected cells Expressed 
cell line HLA gene 
W6/32.HL 4E 2BC4 TIJ 109 
Zla a3 Z 7 579* 16 734 27 659 253 B14 
Z8b a2 Z 3 500 4485 5 260 134 B14 
Z5a b2 Z 11 637 11 896 228 2426 B38 
S13b a3 S 14 144 15 701 20258 290 B39 
S14a bl S 8 725 7 221 11297 148 B39 
S1. l .a S 483 638 423 268 B44?? 
$2.1 .c S 830 986 340 260 B44?? 
BII3 432 258 472 291 none 
* cpm (average of three triplicates). 
BII3 is a cell line transfected with the thymidine kinase gene of herpes simplex, but not with an HLA gene. 
or $2.1 .c of donor Z suggested that these clones encoded 
HLA-Bw44.2. 
Sequences of B38 and B39 genes. The exons encoding the 
first three extracellular domains of the B38 and B39 genes 
were sequenced (Fig. 1). The leader peptide of both genes 
was identical to that of B7 (Biro et al. 1983). HLA-B38 
was found to differ from HLA-B39 in only seven 
nucleotide substitutions confined to exon 2 encoding the 
(~1 domain. From an overall comparison of their 
Exon 2 
translated protein sequences with other known HLA class 
HLA-B38 
I proteins (Fig. 2), HLA-B39 shows identity with HLA- HLA-B3g 
B14 in the c~l domain, whereas HLA-B38 differs from HLA-B38 
HLA-B14 at six positions between the residues 74-83. HLA-B39 
HLA-B38 Within this region, HLA-B38 is completely identical to HLA-B39 
HLA-B58 (Ways et al. 1985), B-51 and B-52 (Hayashi et HLA-B38 
al. 1989). Within exon 3, HLA-B38 and -B39 exhibit iden- HLA-B39 
tical unique sequences at the codons 106, 107, 158, 167, HLA-B39HLA-B38 
and 168 in comparison with other known HLA-A, -B, C 
genes. At codons 113 and/or 114, HLA-B38 and -B39 Exon 3 
share nucleotides with HLA-B13 (Zemmour et al. 1988), HLA-B38 HLA-B39 
-B58 (Ways et al. 1985), -B60, -B40* (Ways et al. 1987), HLA-B3B 
-B14, -B65, -B42, -B18 (Parham et al. 1988), -B7.1, and HLA-B39 
B7.2 (Orr et al. 1979, Ldpez de Castro et al. 1979). The HLA-B38 HLA-B39 
nucleotide sequence at codon 116 of HLA-B38 and -B39 HLA-B38 
is also identical to HLA-B14 and -B65 (Parham et al. HLA-B39 
1988). At position 131, HLA-B38 and -B39 differ from HLA-B38 
HLA-B39 
the consensus equence (Parham et al. 1988) in a further 
nucleotide xchange producing serine instead of arginine, 
as demonstrated already in another group of HLA-B 
molecules (Parham et al. 1988). In all other positions of 
exon 3, the cloned genes were identical to the consensus 
sequence shared by many HLA-B alleles (Parham et al. 
1988). 
Genetic polymorphism of the Bw4 and Bw6 specificities. 
The sequence differences between HLA-B38 and -B39 
were related to protein data of other HLA class I 
molecules to define the genetic basis of the serological 
polymorphism of the Bw4 and Bw6 and of the HLA- 
B16-related subtypic specificities. The seven nucleotide 
exchanges between the Bw4-positive HLA-B38 and the 
Bw6-positive HLA-B39 genes lead to six amino acid 
substitutions between positions 74 and 83 (Figs. 1 and 2). 
At amino acid position 77, as well as at positions 80-83, 
HLA-B39 is identical to all other Bw6-positive HLA-B 
molecules, as well as HLA-Cw3 which also carries the 
(al-domai n) 60 
i 
GGCTCCCACT CCATGAGGTA TTTCTACACC TCCGTGTCCC GGCCCGGCCG CGGGGAGCCC 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
120 
CGO'TCATCT CAGTGGGCTA CGTGGACGAC ACGCAGTTCG TGAGGTTCGA CAGCGACGCC 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
180 
GCGAGTCCGA GAGAGGAGCC GCGGGCGCCG TGGATAGAGC AGGAGGGGCC GGAATATTGG 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
240 
GACCGGAACA CACAGATCTG CAAGACCAAC ACACAGACTT ACCGAGAGAA CCTGCGGATC 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  G . . . . . . . . .  G . . . . . . . .  A- 
GCGCTCCGCT ACTACAACCA GAGCGAGGCC 
CT--G-G . . . . . . . . . . . . . . . . . . . . . . .  
(a2-domain) 601 
GGGTCTCACA CCCTCCAGAG GATGTACGGC TGCGACGTGG GGCCGGAACG GCGCCTCCTC! 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
120 
CGCGGGCATA ACCAGTTCGC CTACGACGGC AAGGATTACA TCGCCCTGAA CGAGGACCTG 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
leO1 
AGCTCCTGGA CCGCCGCGGA CACCGCGGCT CAGATCACCC AGCGCAAGTG GGAGGCGGCCI 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
240 
CGTGTGGCGG AGCAGCTGAG AACCTACCTG GAGGGCACGT GCGTGGAGTG CGTCCGCAGAI 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
TACCTGGAGA ACGGGAAGGA GACGCTGCAG CGCGCG 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Exon 4 (~3-domain) 60 
HLA-B38 GACCCCCCAA AGACACATGT GACCCACCAC CCCATCTCTG ACCATGAGGC CACCCTGAGG! 
HLA-B39 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
120 
HLA-B38 TGCTGGGCCC TGGGCTTCTA CCCTGCGGAG ATCACACTGA CCTGGCAGCG GGATGGCGAG 
HLA-B39 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
180 
HLA-B38 GACCAAACTC AGGACACCGA GCTTGTGGAG ACCAGACCAG CAGGAGACAG AACCTTCCAG 
HLA-B39 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
2401 
HLA-B38 AAGTGGGCAG CTGTGGTGGT GCCTTCTGGA GAAGAGCAGA GATACACATG CCATGTACAG: 
HLA-B39 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
HLA-B38 CATGAGGGGC TGCCGAAGCC CCTCACCCTG AGATGG 
HLA-B39 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  
Fig. 1. DNA sequence of the second and third exons of the HLA-B38 
and HLA-B39 genes. 
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Fig. 2. Amino acid sequence comparison of HLA-B38 and HLA-B39 with other HLA-A, B, C molecules in the otl and o~2 domain. The dashed 
indicate identity with the consensus equence derived from the sequences shown. The sequences were obtained from the following references: B27.1 
(Weiss et al. 1985) and variants (Vega et al. 1986); B44.1 (Kottmann et al. 1986); B44.2 (Parham et al. 1988); B13 and B47 (Yang 1989); A1, 
Bw65, B14, B18, B41, B42 (Parham et al. 1988); Bw60, B40* (Ways et al. 1987); B8 (Parham et al. 1988); B7.1 and B7.2 (Cowan et al. 1987, 
L6pez de Castro et al. 1979); Bw58 (Ways et al. 1985); A2.1 (Koller and Orr 1985); A24 (N'Guyen et al. 1985); A3.1 (Strachan et al. 1984); 
AI 1 (Cowan et al. 1987), A32 (Wan et al. 1986); Cw3 (Sodoyer et al. 1984); Cwl, Cw2 (Giissow et al. 1987); B51 and B52 (Hayashi et al. 1989); 
B51EW and Bw62 (Pohla et al. 1989); Aw69 and Aw68 (Holmes et al. 1987). 
Bw6 determinant. The sequence LRG at positions 81-83 
is also shared by all known HLA-A allelic products. In 
contrast, HLA-B38 is homologous to HLA-B58, -B51, 
and -B52 at amino acid position 77, as well as in the se- 
quence IALR at positions 80-83. All other Bw4-positive 
HLA-B as well as -A allelic products are identical only 
in arginine at residue 83 and differ at positions 77 and 
80-82. Thus, Bw4-positive HLA class I molecules may 
carry TLLR, TRLR, TALR, TAAR at positions 80-83 
and asparagine, serine, or aspartatic acid at residue 77. 
Arginine at position 79 is shared by all HLA-B and -C 
molecules, but not by Bw4/Bw6-negative HLA-A 
molecules. The change of tyrosine in HLA-B38 to aspartic 
acid in HLA-B39 at position 74 is also found in other 
HLA-B or -C molecules independent of their expression 
of the Bw4 or Bw6 specificities and implies a charge dif- 
ference of these molecules. 
Serological polymorphism of the HLA-Bw4 or -Bw6 
specificities. To correlate genetic with serological 
heterogeneity of the HLA-Bw4 and -Bw6 specificities, 
transfectants carrying defined HLA class I genes, as well 
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Table 2. Serological characterization f  HLA-Bw4/Bw6 on trans fectants and Tenth International Histocompatibi l ity Workshop B-cell lines and correla- 
tion with amino acid sequence data of  the c~l domain at residues 77 and 80-83.  
Cells HLA Amino acid sequence 
phenotype 
Bw4 and Bw6 correlated reactivity of  different monoclonal 
antibodies 
77 80-83 Anti-Bw4 Anti-Bw6 
TI]48 TO 109 2BC4 SFRS.B6 
Transfectants 
Z5 B38(Bw4) N IALR + + + - - 
HII3 B27. l (Bw4) D TLLR + + + - - 
III 1 B51 (EW)(Bw4) N TRL R + + + - - 
$13b B39(Bw6) S NLRG - - + + + + 
Z la  Bw64(Bw6) S NLRG***  - - + + + + 
DII B7(Bw6) S NLRG - - + + + + 
GII3 Cw3(Bw6) S NLRG - - - + + 
CII3 A2 D TLRG . . . .  
B-cell lines 
WS 9050 B44. l**(Bw4) N TAAR*** + 
WS 9001 A24. l(Bw4) N IALR*** + + 
WS 9035 A32(Bw4) S IALR*** + + 
Binding activity in an indirect immunofluorescence assay: + +,  strong binding; +,  weak binding; - ,  no reactivity; **, IEF defined variants; *** 
presumed sequence data according to published gene sequences derived from other cell lines. 
as B-cell lines with serologically and immunochemically 
well-characterized HLA class I antigens, were analyzed 
for their reactivity with various Bw4- and Bw6-specific 
monoclonal ntibodies (Table 2). Comparison of available 
protein sequence data with binding..patterns of monoclonal 
reagents revealed that he mAb TU48 (M~iller et al. 1982) 
reacted with all tested cells expressing the HLA-Bw4 
determinant. Sequence variability in positions 77 and 
80-82 appeared to correlate with variability in binding ac- 
tivity of T(J48. However, the mAb T(Jl09 (Mfiller et al. 
1985a) only recognized Bw4 + HLA-B antigens except 
B44.1. This antibody did not react with HLA-A molecules 
in spite of shared amino acid sequences at positions 77 
and 80-83. The Bw6-specific antibody 2BC4 (Kandzia et 
al. 1981) reacted only with the transfected cell lines ex- 
pressing Bw6 + HLA-B molecules, whereas the antibody 
SFR8-B6 (Radka et al. 1982) also recognized HLA-Cw3. 
Discussion 
Primary structure of the HLA-B split antigens B38 and 
B39 was determined to identify the amino acid substitu- 
tions responsible for the Bw4 and Bw6 specificities. HLA- 
B38 and -B39 are serologically difficult to distinguish by 
their private pitopes, but are clearly dissimilar in the Bw4 
determinants. Previous comparison of HLA sequences 
(Parham et al. 1988, Wan et al. 1986) and exon shuffling 
experiments (Toubert et al. t988) suggested positions 
79-83 of the c~l domain to generate the Bw4 and Bw6 
determinants. In this study, amino acid substitutions at 
positions 77, as well as at positions 80-83, are shown tO 
contribute to the serologically defined Bw4 and Bw6 
specificities and to correlate with reactivity patterns of 
monoclonal antibodies and alloantisera revealing 
heterogeneity and different epitopes of these antigens. 
As has been shown for other serologically highly 
cross-reactive subtypes of HLA antigens, HLA-B38 and 
-B39 are very similar in their amino acid sequences, 
revealing only six amino acid differences within a limited 
region of high polymorphism in the c~l domain. When 
compared with other defined HLA molecules (Parham et 
al. 1988), B39 and B38 reveal unique sequences only in 
the c~2 domain. According to the X-ray crystallographic 
structure of HLA-A2, the specific positions 106 and 107 
are possibly situated on a loop outside the antigen binding 
site, and amino acid 167 at the c~2-helical region is mos~ 
likely involved in peptide binding. Positions 158 and 168 
probably interact with the T-cell receptor (Bjorkman et 
al. 1987). The complete identity of exon 2 and shared 
substitutions of exon 3 indicate that HLA-B39 and -B14 
could be derived from a common ancestor by a process 
involving intrallelic exchange events and point mutations, 
as has been suggested for other HLA alleles (Parham et 
al. 1988). No serological cross-reactivity between B14 
and B39, with the exception for the Bw6 epitope, has been 
observed; thus, the corresponding allotypic reagents may 
preferentially be directed against epitopes located on the 
C.A. Miiller et al.: Genetic heterogeneity of the HLA-Bw4 and -Bw6 specificities 205 
c~2 domain. Since HLA-B38 shares nucleotides with HLA- 
B58 (Ways et al. 1985), -B51, and -B52 (Hayashi et al. 
1989) at codons 74-83, it could have been generated in 
one step from B39 by a single exchange vent in which 
for example HLA-B58, -B51, or -B52 donated another 
DNA segment encompassing codons 74-83. HLA-B39 
which shares the entire c~l domain with HLA-B14, could 
thus be the older of the two genes. Alternatively, HLA- 
B38, -B39, and -B14 could have diverged simultaneously 
from a common ancestor by several steps of exchange 
events or point substitutions. 
As the DNA segment flanked by codons 74 and 83 
is the only region of the polymorphic c~l and a2 domains 
in which HLA-B38 and -B39 are different from each other, 
both subtypic epitopes, as well as the public determinants 
Bw4 or Bw6 on these molecules must be encoded within 
this area. The amino acid sequence SLRNLRG of HLA- 
B39 between residues 77 and 83 correlates completely 
with Bw6 of all other known HLA-B and -C antigens. 
According to the amino acid sequences, Bw6 is 
distinguishable from other HLA-A, -B, -C molecules only 
by the simultaneous presence of serine at position 77 and 
asparagine at position 80. In comparison, the HLA-Bw4 
specificity could be related in HLA-B38 to the amino acid 
substitution asparagine at position 77 and the sequence 
IALR at residues 80-83. Similar substitutions, most likely 
generated by interlocus exchange processes, have already 
been found in the HLA-A molecules A32, and A24 carry- 
ing the Bw4 determinant (Wan et al. 1986), and were also 
shown to code for Bw4 in the HLA-B58 (Ways et al. 
1985), -B51, -B52 (Hayashi et al. 1989), and -B27.2 
(Vega et al. 1986) molecules. The same polymorphic 
Bw4-related substitutions have also been observed in 
chimpanzees' B-locus antigens (Mayer et al. 1988, 
Lawlor et al. 1988) and therefore may predate divergence 
of human and chimpanzees MHC products. In other HLA- 
B molecules, alternative sequences between residues 79 
to 83 were previously claimed to also be associated with 
the Bw4 determinant (Wan et al. 1986). Except for B44.1, 
these HLA-B molecules hare the amino acids leucine and 
arginine at residues 82 and 83 with HLA-B38, but differ 
from Bw4- HLA-A or Bw6 § HLA-B antigens at posi- 
tions 77 and 80-81. Thus, in contrast o HLA-Bw6, at 
least seven different patterns of the amino acid sequence 
between positions 77 and 83 could be related to HLA- 
Bw4. Rearrangement of small elements of sequences 
through gene conversion or intra-allelic exchange vents, 
of which an example could be NLR found at positions 
77-79 in Bw4 and at residues 80-82 in Bw6, in addition 
to point mutations, most likely have been involved in the 
generation of amino acid sequence variation associated 
with these public HLA-B specificities. 
Variable amino acid sequences are likely to also ac- 
count for the serological differences of the HLA-Bw4 and 
-Bw6 specificities (MOiler et al. 1985a, Mtiller et al. 1982, 
Layet et al. 1985). The observed weak correlation coeffi- 
cients of Bw4- versus Bw6-specific alloantisera nd 
monoclonal ntibodies (Arnaiz-Villena et al. 1989) appear 
to reflect the genetic variability of these public 
specificities. Reactivity patterns of monoclonal ntibodies 
on transfectants or B-cell lines allow differentiation oftwo 
alloantigenic epitopes associated with Bw4 formed by the 
c~ helix of the ~1 domain between residues 77 and 83. 
One epitope which is suggested tocontact the T-cell recep- 
tor according to the X-ray crystallographic structure of 
HLA-A2 is shared by alt Bw4 + HLA-B antigens, as well 
as by the HLA-A molecules A24, and A32, and is 
recognized by the Bw4-specific antibody T048. This 
epitope has also been defined by alloantisera (Kostyu et 
al. 1980). Binding of TU48 most likely involves interac- 
tion, particularly with the amino acids leucine and 
asparagine, at residues 82 and 83 which are shared by all 
Bw4 + HLA-A and -B antigens. The other Bw4 epitope 
is only present on HLA-B molecules and is discriminated 
by antibodies like TU109. Reactivity of this antibody may 
rely on a particular protein conformation i duced at the 
co-helical region by different amino acids at residues 77, 
80, 81, and 82. This is suggested by selective binding of 
T~Jl09 to Bw4 + HLA-B, but not -A, molecules inspite 
of amino acid sequence variation, and could also explain 
the lack of reactivity with HLA-Bw44.1, exhibiting a 
specific Bw4-related amino acid sequence N, TAAR at 
these positions. According to the differential reactivity 
pattern of the antibodies SFR8-B6 and 2BC4 on transfec- 
tants, the Bw6 specificity could also include two epitopes. 
One is most likely recognized by the antibody SFR8-B6 
directed against Bw6 + HLA-B and -C molecules, 
whereas the other one may be differentiated by 2BC4 
selectively binding to HLA-B antigens. SFR8-B6 appears 
to interact predominantly with amino acid residues 80-83, 
whereas 2BC4 seems to react particularly with amino 
acids at positions 80-77. Conformational changes of the 
2BC4-defined epitope in HLA-Cw3 through amino acid 
substitutions in the immediate neighboring positions (i. e., 
exchange of valine in HLA-Cw3 for glutamic acid at posi- 
tion 76 in HLA-B molecules) could explain lack of reac- 
tivity of 2BC4 with HLA-Cw3. Thus, both public 
specificities HLA-Bw4 and -Bw6 appear to be 
characterized by one epitope distant from amino acid seg- 
ment 62-76 with greatest sequence diversity of the c~l do- 
main, as well as by another epitope next to this area. Reac- 
tivity of the mAbs T0109 and 2BC4 indicate that the 
three-dimensional structure of the latter epitope may be 
influenced by amino acid substitutions in the region of 
high diversity. The subtypic epitope of HLA-B38 and 
-B39, which can be differentiated from the Bw4 or Bw6 
specificity by specific alloantisera, is most likely formed 
by the amino acid exchange at position 74. It seems to 
be spatially distinct from the public specificities Bw4 and 
Bw6 in these molecules, whereas in other HLA-B antigens 
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such as the B27 variants, overlapping of public and private 
epitopes, may occur, as is suggested by the reactivity pat- 
tern of specific mAbs like TM1 (Thurau et al. 1989). 
Therefore, recognition of this epitope by Bw4- or 
Bw6-specific antisera may depend on similar conforma- 
tion, but not neccessarily on identity of the amino acid 
sequence. 
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